BPC-157 & TB-500 (Wolverine Stack) Dosage Guide
45/100 confidenceComplete guide to BPC-157 & TB-500 (Wolverine Stack) dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
250 mcg - 500 mcg
Frequency
2x daily
Cycle Length
4-8 weeks
Reconstitution
Vial Size
10 mg
BAC Water
2 ml
Concentration
5,000 mcg/ml
Detailed Dosage Information
Typical research protocols: BPC-157 at 250-500mcg daily combined with TB-500 at 2-2.5mg twice weekly during loading phase, then 2mg every 2 weeks for maintenance.
Administration Method
Both peptides administered via subcutaneous injection. Some protocols suggest injecting near injury sites for localized effects. Can be injected separately or as a pre-mixed blend.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Quick Calculator
Concentration: 5,000 mcg/ml
Volume to inject: 0.05 ml
Syringe units (U-100): 5.0 units
Pre-filled with BPC-157 & TB-500 (Wolverine Stack) defaults. Adjust values as needed.
Research Backing
Animal synergy studies; BPC pilots \+ TB-4 (thymosin beta-4) preclinical data; widespread observational use in regenerative research.
Side Effects to Monitor
Generally well-tolerated. May include mild nausea, temporary fatigue, headache, or localized irritation at injection sites.
Safety Considerations & Risks
Limited human clinical trial data for the combination. Theoretical concerns about promoting growth of existing cancers due to angiogenic properties. Not FDA approved for human use.